Connectyx in Licensing Discussions for Novel Monoclonal Antibody to Treat Pediatric Glioblastoma
July 06, 2020 09:30 ET
|
Connectyx Technologies Holdings Group, Inc
Boca Raton, FL, July 06, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel...
Connectyx Welcomes I. Richard Garr, Esq. to Company’s Scientific Advisory Board
May 19, 2020 09:30 ET
|
Connectyx Technologies Holdings Group, Inc
Company Reports First Quarter Results Boca Raton, FL, May 19, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development stage...